|
Micro-Cap Launches National Infomercial For Psoriasis Product, Stock Near 52 Week High
By: AllPennyStocks.com News
August 25, 2009
Millions who suffer with the misery of psoriasis should mark Monday, Aug. 24 on their calendars, for it was that day that their tormentor should consider its days numbered.
On cable TV systems all over America, British Columbia-based biotechnology company avVaa World Health Care Products Inc. (Pink Sheets:AVVH) ratchets up its campaign to make known its flagship product, Neuroskin® Psoriasis Relief, in 46 commercial spots, as part of a one-week media test Direct Response Television (DRTV) advertising campaign. The spots – one in 60-second commercial format, the other, an 120-second infomercial - will be aired on such prestigious cable carriers as BBC America, American Movie Classic, Style, DIY, Hallmark Movies, Women’s Entertainment TV and VH1 Classic. The campaign could reach upwards of 100’s of Million of subscribers
Each DRTV announcement contains an offer that urges immediate action from the viewer, and management of AVVH is confident the campaign will ramp up orders for Neuroskin, and noticeably boost its bottom line, a boost that small cap investors will sit up and take notice of, particularly if they don’t yet have this stock on their radar screen.
The company closed out last week with news of its new marketing website, www.MyNeuroskin.com, meant to act as the landing page and internet focal point for the Neuroskin marketing campaign. avVaa President and COO Lorie Campbell-Farley has been quoted as saying, “With approximately 450 million subscribers to these channels, we expect maximum viewership and a very strong response.”
Campbell-Farley added, “We anticipate generating at least $1.80 in sales for every dollar we spend during our launch week.”
AVVH is poised to manufacture and market its Over The Counter Neuroskin®) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada.
Whether because the buzz is getting around about the effectiveness of Neuroskin or not, the stock has been rumbling in recent weeks. Listed on the Pink Sheets, AVVH lurked below the penny mark per share for months at a time, breaking past that barrier only in April, and once again in July, finally hitting its 52-week high of 2.4 cents in mid-August. The share price lingered around 1.75 cents as the Company was in the one-week TV ad campaign. Whether the stock clicks as more folks click into the site – and the infomercials – is something that remains to be seen. Also, if this media test is a success, the Company is planning a full national infomercial campaign that will no doubt bring in massive exposure to this micro-caps flagship psoriasis product.
Copyright © 2009 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
AllPennyStocks.com has been compensated sixty eight Million rule-144 shares by the company for its efforts in presenting the AVVH profile on its web site and distributing it to its database of subscribers as well as other services.
|
